The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT)
1University of Sheffield, Sheffield, UK; 2University of Auckland, Auckland, New Zealand; 3University of Pittsburgh, Pittsburgh, Pennsylvania, USA; 4Katholieke Universiteit Leuven, Leuven, Belgium; 5Helen Hayes Hospital, West Haverstraw, New York, USA; 6Chinese University of Hong Kong, Hong Kong, China; 7Semmelweis University Medical School, Budapest, Hungary; 8Centro Tratamiento Integral Endocrinología, Buenos Aires, Argentina; 9San Francisco Coordinating Center, San Francisco, California, USA; 10University of California, San Francisco, California, USA; 11Novartis Pharmaceuticals, East Hanover, New Jersy, USA.
ea0025p18